Fingerprint
Dive into the research topics where Femke Spoelstra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy
van Rossum, P. S. N., Wolfhagen, N., van Bockel, L. W., Coremans, I. E. M., van Es, C. A., van der Geest, A. M., de Jaeger, K. E. A., Wachters, B., Knol, H. P., Koppe, F. L. A., Pomp, J., Reymen, B. J. T., Schinagl, D. A. X., Spoelstra, F. O. B., Tissing-Tan, C. J. A., Peters, M., van der Voort van Zijp, N. C. M. G., van der Wel, A. M., Wiegman, E. M. & Wijsman, R. & 2 others, , 1 Nov 2024, In: Journal of thoracic oncology. 19, 11, p. 1550-1563 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile28 Downloads (Pure) -
Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer
Ronden, M. I., Bahce, I., Hashemi, S. M. S., Dickhoff, C., de Haan, P. F., Becker, A., Spoelstra, F. O. B., Dahele, M. R., Ali, R., Tiemessen, M. A., Tarasevych, S., Maassen van den Brink, K., Haasbeek, C. J. A., Daniels, J. M. A., van Laren, M., Verbakel, W. F. A. R. & Senan, S., 1 Feb 2021, In: Lung Cancer. 152, p. 149-156 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Relationship between treatment plan dosimetry, toxicity, and survival following intensity-modulated radiotherapy, with or without chemotherapy, for stage iii inoperable non-small cell lung cancer
de Vries, I. F. R., Ronden, M. I., Bahce, I., Spoelstra, F. O. B., de Haan, P. F., Haasbeek, C. J. A., Lissenberg-Witte, B. I., Slotman, B. J., Dahele, M. & Verbakel, W. F. A. R., 1 Dec 2021, In: Cancers. 13, 23, 5923.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile19 Downloads (Pure) -
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis
Ronden, M. I., Bahce, I., Claessens, N. J. M., Barlo, N., Dahele, M. R., Daniels, J. M. A., Tissing-Tan, C., Hekma, E., Hashemi, S. M. S., van der Wel, A., Spoelstra, F. O. B., Verbakel, W. F. A. R., Tiemessen, M. A., van Laren, M., Becker, A., Tarasevych, S., Haasbeek, C. J. A., Maassen van den Brink, K., Dickhoff, C. & Senan, S., 1 Jul 2021, In: JTO Clinical and Research Reports. 2, 7, 1 p., 100195.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Treatment Plan Parameters and Toxicity Following Chemoradiotherapy and High-Dose Radiotherapy in Stage III Non-Small Cell Lung Cancer
De Vries, I. R., Ronden, M., Bahce, I., Dahele, M., Spoelstra, F., De Haan, P., Haasbeek, C., Lissenberg-Witte, B., Slotman, B. & Verbakel, W., Oct 2021, In: Journal of thoracic oncology. 16, 10, p. S1048-S1048Research output: Contribution to journal › Meeting Abstract › Academic